Alnylam Pharmaceuticals (ALNY)
NASDAQ:ALNY
ALNYAlnylam Pharma
$182.41
$0.6 (0.33%)

Alnylam Pharma Earnings Date & Forecast

Earnings Data

Report Date
Aug 03, 2021
Pre-Market Not Confirmed
Period Ending
2021 (Q2)
Consensus EPS Forecast
-$1.61
Last Year’s EPS
-$1.56
Same Quarter Last Year
Analyst ConsensusModerate Buy
Based on 12 Analysts Ratings

Alnylam Pharma (ALNY) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

ALNY Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Aug 03, 2021
2021 (Q2)
-1.61 / -
-1.56
Apr 29, 2021
2021 (Q1)
-1.75 / -1.71
-1.616
-5.88% (-0.09)
Feb 11, 2021
2020 (Q4)
-1.78 / -2.09
-2.471
15.26% (+0.38)
Nov 05, 2020
2020 (Q3)
-1.63 / -2.18
-1.918
-13.87% (-0.27)
Aug 06, 2020
2020 (Q2)
-1.72 / -1.56
-2.022
22.85% (+0.46)
May 06, 2020
2020 (Q1)
-1.89 / -1.62
-1.726
6.37% (+0.11)
Feb 06, 2020
2019 (Q4)
-2.21 / -2.47
-2.092
-18.12% (-0.38)
Oct 31, 2019
2019 (Q3)
-2.07 / -1.92
-2.434
21.20% (+0.52)
Aug 06, 2019
2019 (Q2)
-2.12 / -2.02
-1.627
-24.28% (-0.39)
May 01, 2019
2019 (Q1)
-2.12 / -1.73
-1.412
-22.24% (-0.31)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

ALNY Earnings Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Apr 29, 2021
$143.53
$140.64
-2.01%
Feb 11, 2021
$164.16
$157.92
-3.80%
Nov 05, 2020
$139.49
$130.73
-6.28%
Aug 06, 2020
$150.44
$143.53
-4.59%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis